Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation

Cancer Research

Volumn 62, Issue 10, 2002, Pages 2957-2961

  Turner, Kevin J ^a   Moore, John W ^a   Jones, Adam ^a   Taylor, Claire F ^b   Cuthbert Heavens, Darren ^b   Han, Cheng ^a   Leek, Russell D ^a   Gatter, Kevin C ^a   Maxwell, Patrick H ^c   Ratcliffe, Peter J ^c   Cranston, David ^d   Harris, Adrian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; UBIQUITIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; KIDNEY CANCER; KIDNEY TUMOR; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; AGED; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; LIGASES; MALE; MIDDLE AGED; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0037093238     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Candidate genes for the hypoxic tumor phenotype
2. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
3. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
4. 2 tension
5. Regulation of hypoxia-inducible factor α a is mediated by an oxygen-dependent domain via the ubiquitin-proteasome pathway
6. Endothelial PAS domain protein I (EPAS1), a transcription factor selectively expressed in endothelial cells
7. Induction of endothelial PAS domain protein-1 by hypoxia: Characterisation and comparison with hypoxia-inducible factor-1α
8. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
9. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
10. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
11. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
12. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von-Hippel Lindau protein
13. E. Mutations of the VHL tumor suppressor gene in renal carcinoma
14. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
15. Contemporary approach to the classification of renal epithelial tumors
16. Improved RNase protection assay for quantifying LDL-receptor mRNA: Estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells
17. The expression and distribution of the hypoxia inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumour associated macrophages
18. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
19. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning
20. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
21. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau turnout suppressor gene
22. The turnout suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
23. Up-regulation of the hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
24. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein I (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma
25. Up-regulation of vascular endothelial growth factor in stromal cells of haemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α
26. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling
27. Hypoxia-inducible-factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumor growth
28. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
29. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
30. Expression of hypoxia-inducible factor-1α in brain tumors: Association with angiogenesis, invasion, and prognosis
31. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas
32. Suppression of tumor growth through disruption of hypoxia-inducible transcription